CELL INTELLIGENCE · 肿瘤细胞治疗研究

微流控 Cytotongue 系统实现肿瘤球体中 CAR-T 诱导机械软化的早期无标记检测

Microfluidic Cytotongue system enables early, label-free detection of CAR-T-induced mechanical softening in tumor spheroids.

乳腺癌化疗的转型：预测标志物、耐药机制和新的治疗方法

Breast cancer chemotherapy in transition: predictive markers, resistance mechanisms, and new treatment approaches.

一种肿瘤靶向七甲川花菁染料通过诱导致死性自噬抑制三阴性乳腺癌

A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagy.

本研究介绍了一种可能有效增强 TNBC 治疗效果的策略。

乳腺癌中 CD39 和 CD73 的表达：CD73 作为 HER2 阳性肿瘤的有利预后因素

CD39 and CD73 Expression in Breast Cancer: CD73 as a Favorable Prognostic Factor in HER2-Positive Tumors.

乳腺癌各亚组中 CD39 与 CD73 的表达比例随激素受体状态和 HER2 状态而不同，且 TILs 中 CD73 表达与 HER2 阳性乳腺癌预后良好的趋势相关。

用于癌症免疫治疗的离体扩增 NK 细胞的表征

Characterization of ex vivo expanded natural killer cells for cancer immunotherapy.

晚期乳腺癌免疫治疗：NK 细胞表面修饰以嵌入抗体药物偶联物

Advanced breast cancer immunotherapy: Surface modification of NK cells for embedding antibody-drug conjugates.

乳腺癌中与组织学免疫特征相关的基因组特征

Genomic Characteristics Related to Histology-Based Immune Features in Breast Cancer.

高 TIL 乳腺癌的免疫环境：三阴性与激素受体阳性 HER2 阴性

Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative.

HR⁺ 乳腺癌中 SPP1⁺ 巨噬细胞与 TIL（肿瘤浸润淋巴细胞）相关

SPP1+ macrophages in HR+ breast cancer are associated with tumor-infiltrating lymphocytes.

TIL（肿瘤浸润淋巴细胞）水平与剪切波弹性成像所测较低硬度持续相关：其在乳腺癌中意义的亚型特异性分析

Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its